CSGA

CSGA Protein

Score: 0.521 Price: $0.45 Medium Druggability Status: active
HYPOTHESES
1
PAPERS
11
KG EDGES
0
DEBATES
0

Druggability & Clinical Context

Druggability
Medium
Score: 0.50
Clinical Stage
Phase I
Target Class
Protein
Safety
0.50
Druggability Analysis
Drug Development0.00
Structural Tractability0.30
Target Class0.50
Safety Profile0.50
Key Metrics
PDB Structures:
0
Known Drugs:
0
Approved:
0
In Clinical Trials:
0
Therapeutic Areas:
neurodegeneration
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding
Known Drugs:
No known drugs targeting this protein
Structural Data:

Linked Hypotheses (1)

Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cross-Seeding0.488

Linked Experiments (0)

No linked experiments

Scoring Dimensions

Portfolio 0.00 (25%) Druggability 0.50 (20%) Evidence 0.79 (20%) Safety 0.50 (15%) Competitive 0.90 (10%) Connectivity 0.00 (10%) 0.521 composite

Knowledge Graph (20)

activates (1)

CSGA APP

associated with (4)

CSGA neurodegeneration
CSGA Rb
CSGA Alzheimer
CSGA Als

co associated with (3)

CSGA TLR4
CSGA GPR109A
CSGA TDC

debate co mention (4)

CSGA GPR109A
CSGA neuroinflammation
CSGA TDC
CSGA DDC

implicated in (5)

CSGA ms
CSGA parkinson
CSGA als
CSGA alzheimer
CSGA neurodegeneration

interacts with (1)

CSGA Rb

regulates (2)

CSGA Als
CSGA Parkinson

Debate History (0)

No debates yet